Absci Corp. (ABSI)
9.04
-0.63
(-6.51%)
USD |
NASDAQ |
Oct 13, 15:24
Absci Free Cash Flow : -108.97M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -108.97M |
| March 31, 2026 | -98.50M |
| December 31, 2025 | -94.03M |
| September 30, 2025 | -81.94M |
| June 30, 2025 | -76.73M |
| March 31, 2025 | -76.81M |
| December 31, 2024 | -72.81M |
| September 30, 2024 | -70.76M |
| June 30, 2024 | -60.65M |
| March 31, 2024 | -62.96M |
| December 31, 2023 | -65.50M |
| September 30, 2023 | -69.68M |
| Date | Value |
|---|---|
| June 30, 2023 | -82.93M |
| March 31, 2023 | -89.91M |
| December 31, 2022 | -97.51M |
| September 30, 2022 | -103.78M |
| June 30, 2022 | -107.24M |
| March 31, 2022 | -113.00M |
| December 31, 2021 | -98.64M |
| September 30, 2021 | -76.69M |
| June 30, 2021 | -52.77M |
| March 31, 2021 | -24.18M |
| December 31, 2020 | -13.15M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Twist Bioscience Corp. | -93.22M |
| Prime Medicine, Inc. | -156.85M |
| Beam Therapeutics, Inc. | -372.77M |
| Moderna, Inc. | -1.244B |
| Tenax Therapeutics, Inc. | -46.03M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.56M |
| Cash from Investing (Quarterly) | 24.07M |
| Cash from Financing (Quarterly) | 102.73M |
| Free Cash Flow Per Share (Quarterly) | -0.175 |
| Free Cash Flow to Equity (Quarterly) | -26.98M |
| Free Cash Flow to Firm (Quarterly) | -27.56M |
| Free Cash Flow Yield | -7.97% |